NL-OMON37397已完成不适用
A pharmacokinetic study to compare the bioavailability between MK-0663 (etoricoxib ) 120 mg Tablets from Two Different Manufacturing Sites (Frosst Iberica, Spain versus Elkton, VA, USA). - MK-0663 (CS0177)
Merck Sharp & Dohme (MSD)0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Male and female, between 18-55 years of age, BMI 18-30.
排除标准
- •Clinical significant abnormalities at medical research
研究者
相似试验
已完成
不适用
Evaluation of Pharmacokinetics, Relative Bioavailability, and Safety of PA-101 in Healthy Subjects, Patients with Systemic Mastocytosis, and Patients with Allergic AsthmaBlood and Lymphatic System DisordersSystemic MastocytosisMastocytosis and Asthma1000170810006436NL-OMON41045Patara Pharma, LLC24
已完成
不适用
Evaluation of Pharmacokinetics, Relative Bioavailability, and Tolerability of Three Different Formulations of PA101 in Healthy Subjects, Patients with Systemic Mastocytosis, and Patients with Chronic Cough due to Idiopathic Pulmonary Fibrosisaandoeningen gerelateerd aan de mast cellen (mastocyten)Systemic Mastocytosis and inflammatory10001708NL-OMON42687PATARA PHARMA, LLC24
已完成
1 期
Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.AsthmaNCT01494610GlaxoSmithKline60
已完成
不适用
Pharmacokinetic study to assess the bioavailability of phenolics from an olive leaf extractcardiovascular disease100822061000595910047079osteoporosisNL-OMON37716Bio-Actor31
已完成
不适用
Pharmacokinetic study to assess the bioavailability of the cocoa flavanols catechin and epicatechin from different matrices.1008220610047079cardiovascular diseaseNL-OMON35796Callebaut NV10